Havas Health & You launches cannabinoid-focused agency
Havas ECS will focus on science-based education and communications about cannabinoids.
News
Five things for pharma marketers to know: Tuesday, July 16, 2019
Oklahoma prosecutors compare J&J to drug ‘kingpin’; Biden unveils healthcare plan; Gilead increases stake in Galapagos.
“So, how was your year?” Iskowitz and Dobrow on the making of the Agency 100
Editors Marc Iskowitz and Larry Dobrow unpack MM&M’s Agency 100 issue in this edited transcript of their conversation for The MM&M Podcast.
Condé Nast industries lead draws on health heritage
Jennifer Mormile is chief industries officer and SVP of the lifestyle division at Condé Nast.
Kantar and Bain on their $4bn deal: Now we can invest and acquire more
Staying wholly owned by WPP would have limited ambitions, Kantar CEO says.
J&J’s legal troubles mount
The company’s failed bid to have the Oklahoma opioid case tossed was followed this week by a reported criminal probe into its talcum baby powder.
Five things for pharma marketers to know: Monday, July 15, 2019
Feds to pursue criminal investigation into J&J; 23andMe wants access to medical records alongside DNA; Another Alzheimer’s trial fails.
Global Myopia Awareness Coalition brings on Golin to boost awareness
The coalition is made up of 12 eye-health pharma and biotech companies.
Study: Reach of court-ordered anti-tobacco ads subpar
Researchers looked at the effectiveness of court-ordered anti-smoking campaigns paid for by the tobacco industry.
Want to read more?
Please login or register first to view this content.
